RT Journal Article
SR Electronic
T1 Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for New Zealand (Aotearoa)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.28.21266967
DO 10.1101/2021.11.28.21266967
A1 Watson, Leighton M.
YR 2021
UL http://medrxiv.org/content/early/2021/11/29/2021.11.28.21266967.abstract
AB Aim The New Zealand government is transitioning from the Alert Level framework, which relies on government action and population level controls, to the COVID-19 Protection Framework, which relies on vaccination rates and allows for greater freedoms (for the vaccinated). As restrictions are eased, there is significant interest in understanding the relative risk of spreading COVID-19 posed by unvaccinated and vaccinated individuals.Methods A stochastic branching process model is used to simulate the spread of COVID-19 for outbreaks seeded by unvaccinated or vaccinated individuals. The likelihood of infecting or getting infected with COVID-19 is calculated based on vaccination status.Results A vaccinated traveler infected with COVID-19 is 9x less likely to seed an outbreak than an unvaccinated traveler infected with COVID-19. For a vaccination rate of 50%, unvaccinated individuals are responsible for 87% of all infections whereas 3% of infections are from vaccinated to vaccinated. When normalized by population, a vaccinated individual is 6.8x more likely to be infected by an unvaccinated individual than by a vaccinated individual. For a total population vaccination rate of 78.7%, which is equivalent to the 90% vaccination target for the eligible population (over 12 years old), this means that vaccinated individuals are 1.9x more likely to be infected by an unvaccinated individual than by a vaccinated, even though there are 3.7x more vaccinated individuals in the population.Conclusions This work demonstrates that most new infections are caused by unvaccinated individuals. These simulations illustrate the importance of vaccination in stopping individuals from becoming infected with COVID-19 and in preventing onward transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe MATLAB code produced in the present study is available upon reasonable request to the author.